<DOC>
	<DOC>NCT02630719</DOC>
	<brief_summary>The goal of this study is to determine whether timolol eye drops are effective in alleviating acute migraine headaches. Subjects will be randomized to receive either timolol eye drops or placebo (tears) to use as a migraine abortive medication.</brief_summary>
	<brief_title>Timolol Eye Drops in the Treatment of Acute Migraine Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Diagnosis of migraine headache Exclusion Criteria Nonmigraine headache Use of systemic betablocker Medical history of hypotension, bradycardia, syncope or other significant cardiovascular disease Medical history of difficulty breathing, asthma or chronic obstructive pulmonary disease or other pulmonary disease Medical history of glaucoma, ocular hypertension or hypotony, punctual stenosis, current use of other ophthalmic medications Previous adverse reaction to timolol or other betablockers Inability to selfadminister eye drop due to physical or cognitive disorders Currently pregnant or breastfeeding Pregnant in the past year Nonenglish speaker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>headache</keyword>
</DOC>